Veradermics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-10-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.veradermics.com
Clinical Trials
4
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:3
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 3
1 (25.0%)Safety and Efficacy of VDPHL01 in Males With AGA
Phase 3
Recruiting
- Conditions
- Androgenetic AlopeciaAGAMale Pattern Baldness
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06972264
- Locations
- 🇺🇸
Site 89, Birmingham, Alabama, United States
🇺🇸Site 77, Phoenix, Arizona, United States
🇺🇸Site 93, Northridge, California, United States
Efficacy and Safety of VDPHL01 in Males With AGA
Phase 2
Recruiting
- Conditions
- Androgenetic AlopeciaAGAMale Pattern Baldness
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06724614
- Locations
- 🇺🇸
Site 28, Phoenix, Arizona, United States
🇺🇸Site 23, Rolling Meadows, Illinois, United States
🇺🇸Site 36, Birmingham, Alabama, United States
Safety and Efficacy of VDPHL01 in Males and Females with AGA
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT06527365
- Locations
- 🇺🇸
04, New Albany, Indiana, United States
🇺🇸03, Hackensack, New Jersey, United States
🇺🇸02, South Jordan, Utah, United States
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Phase 2
Completed
- Conditions
- Common WartVerruca VulgarisWarts
- Interventions
- Drug: VDMN-21 Patch Low DoseDrug: VDMN-21 Patch High DoseDrug: Vehicle Patch
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT05799157
- Locations
- 🇺🇸
Site 07, Fort Smith, Arkansas, United States
🇺🇸Site 16, San Diego, California, United States
🇺🇸Site 02, Plainfield, Indiana, United States
News
No news found